Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Angiotensin II type 1 receptor (AT1R) β-arrestin pathway is a signaling cascade initiated by angiotensin II binding to the AT1R, a G protein-coupled receptor. This pathway involves the recruitment of β-arrestins, which desensitize G protein signaling and initiate distinct intracellular signaling cascades, including MAPK activation. This pathway plays a critical role in cardiovascular regulation and is implicated in various cardiovascular diseases. Selective modulation of this pathway is being explored for therapeutic potential.
Activation of β-arrestin signaling upon AT1R stimulation, leading to receptor internalization, desensitization of G protein signaling, and activation of alternative downstream signaling cascades (e.g., MAPK pathways).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiotensin II Type 1 Receptor β-Arrestin Pathway (AT1R β-arrestin pathway).